Use of Cannabis in people with autism spectrum disorder
DOI:
https://doi.org/10.56294/ri202534Keywords:
Cannabis, Autism Spectrum Disorder, Autism, Cannabis OilAbstract
Introduction: Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by impaired communication, social interaction, and repetitive or stereotyped behaviors in those affected. It presents with a wide range of symptoms, which can vary from mild to severe.
Method: a search was conducted in the PubMed, SciELO databases, and the book Cannabis Medicinal. Articles were downloaded from the cited platforms to make the appropriate citations and references in Portuguese, Spanish, and English, covering the last 5 years.
Results: The use of medicinal cannabis in treating Autism Spectrum Disorder (ASD) has shown potential in improving symptoms such as hyperactivity, aggression, self-harm, sleep disturbances, and anxiety. Recent studies highlight that cannabinoids, particularly cannabidiol (CBD), may be a safe and effective option for relieving these symptoms and improving patients' quality of life. However, it is essential to have more robust and long-term research to assess its safety and adverse effects. Despite promising results, the need for professional monitoring and individualized treatment is emphasized to optimize benefits and mitigate possible risks.
Conclusions: this treatment is highly individualized and personalized, encompassing not only pharmacological interventions but also dietary adjustments, supplements, and social behavior strategies, with cannabis use being a supplementary alternative.
References
1. Pina GC, Figueiredo AVSMV, Dos Santos AF, Coppolla MB, Silva IM, Dos Passos PVF, et al. Transtorno do Espectro Autista infantil, Cannabis medicinal e fatores relevantes: revisão de literatura. Braz J Health Rev. 25 de outubro de 2023;6(5):25786–800.
2. Silva Junior EAD, Medeiros WMB, Santos JPMD, Sousa JMMD, Costa FBD, Pontes KM, et al. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial. Trends Psychiatry Psychother [Internet]. 2022 [citado 5 de abril de 2024]; Disponível em: http://www.trends.periodikos.com.br/article/doi/10.47626/2237-6089-2021-0396
3. Mora Vera RC, Solorzano R, Lozano Aveiga JA, Peña Cordero BE. Cannabis as a precursor of psychosis and its relationship with schizophrenia. Salud, Ciencia y Tecnología. 2023;3:262. https://doi.org/10.56294/saludcyt2023262
4. Lima LR, Alencar GSBDC, Dutra TCG, Bezerra CMFMDC, Lima JB, Gusmao EES, et al. Avaliação dos benefícios do uso de canabidiol no tratamento de indivíduos com Transtorno do Espectro Autista (TEA). Braz J Health Rev. 16 de agosto de 2023;6(4):17665–80.
5. Romero MC, Morante M. CANNABIS MEDICINAL - LA GUIACOMPLETA. 1a Ediçao. Ciudad Autónoma de Buenos Aires: Cultivarte SA; 2021.
6. Parrella NF, Hill AT, Enticott PG, Barhoun P, Bower IS, Ford TC. A systematic review of cannabidiol trials in neurodevelopmental disorders. Pharmacol Biochem Behav. setembro de 2023;230:173607.
7. Engler GP, Da Silva GAF, Torres TM, Priscilla D, Lopez AGP, Da Silva MDCS, et al. O uso de Cannabis no tratamento do Transtorno do Espectro do Autismo – revisão sistemática. Braz J Health Rev. 15 de janeiro de 2024;7(1):1301–15.
8. Colacite J, Calixto NM, Rech LPB, Campos LS, Ferreira IPL, Cubas Filho JO, et al. Uso de cannabidiol en el tratamiento del autismo, revisión de la literatura y perspectivas futuras. Res Soc Dev. 15 de março de 2024;13(3):e5113341741.
9. Alves GDS, Fockink JC, Marinho AMDS. Uso do Canabidiol no Transtorno do Espectro Autista, uma revisão integrativa. Braz J Health Rev. 6 de junho de 2023;6(3):12073–88.
10. Carreira LD, Matias FC, Campos MG. Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders. Biomedicines. 29 de março de 2022;10(4):796.
11. Solís Sánchez MI, Flores Guillen SC, Luna Mena MJ, Puedmag Altamirano EC. Analysis of the therapeutic basis of cannabis and its application in medicine. Salud, Ciencia y Tecnología. 2024; 4:937. https://doi.org/10.56294/saludcyt2024937
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Alexandre Matheus Villela Gherardi, Patricia Susana Salguero (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.